Newsroom
Sorted by: Latest
-
MindWalk Holdings Corp. Reports Fiscal 2026 Results: Revenue Up 46% as the Company Completes Its Pivot to Bio-Native AI Infrastructure
AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today reported financial results for the fiscal year ended April 30, 2026. All figures are in Canadian dollars unless otherwise noted. Fiscal 2026 was the year MindWalk completed its transition from building its technology to deploying it. Revenue grew 46% year over year, gross margin expanded, the net loss narrowed by more than half, and the Company divested a non-core business to conc...
-
WEX Inc. Reports Second Quarter 2026 Financial Results
PORTLAND, Maine--(BUSINESS WIRE)--WEX (NYSE: WEX), a global leader in intelligent payment solutions, today reported financial results for the three months ended June 30, 2026. “We are continuing to build momentum, exceeding our guidance ranges once again in the second quarter while advancing our strategic initiatives to accelerate our performance,” said Melissa Smith, WEX’s Chief Executive Officer and President. “The rigor of our investment decisions ensures we are taking advantage of the highe...
-
Primoris Services Corporation Schedules Second Quarter 2026 Earnings Conference Call and Webcast
DALLAS--(BUSINESS WIRE)--Primoris Services Corporation (NYSE: PRIM) (“Primoris” or the “Company”) today announced it will report second quarter 2026 financial results on Tuesday, August 4, 2026, after market close. The Company’s press release will be available on the Primoris website at www.prim.com. In conjunction with the press release, management will host a conference call and webcast on Wednesday, August 5, 2026, at 9:00 a.m. U.S. Central Time (10:00 a.m. U.S. Eastern Time), to discuss the...
-
Pinnacle Financial Partners announces earnings for second quarter 2026
ATLANTA--(BUSINESS WIRE)--Pinnacle Financial Partners, Inc. (NYSE: PNFP) today reported financial results for the quarter ended June 30, 2026....
-
Fiducie de placement immobilier Propriétés de choix présente ses résultats pour le trimestre et le semestre clos le 30 juin 2026
TORONTO--(BUSINESS WIRE)--Fiducie de placement immobilier Propriétés de Choix (« Propriétés de Choix » ou la « Fiducie ») (TSX : CHP.UN) a annoncé aujourd’hui ses résultats financiers consolidés pour le trimestre et le semestre clos le 30 juin 2026. Le rapport du deuxième trimestre aux porteurs de parts peut être consulté sous l’onglet « Investisseurs » du site Web de la Fiducie, à l’adresse www.choicereit.ca/fr, ainsi que sur SEDAR+, à l’adresse www.sedarplus.ca. « Nous sommes ravis des résult...
-
Choice Properties Real Estate Investment Trust Reports Results for the Three and Six Months Ended June 30, 2026
TORONTO--(BUSINESS WIRE)--Choice Properties Real Estate Investment Trust (“Choice Properties” or the “Trust”) (TSX: CHP.UN) today announced its consolidated financial results for the three and six months ended June 30, 2026. The Second Quarter Report to Unitholders is available in the Investors section of the Trust’s website at www.choicereit.ca, and has been filed on SEDAR+ at www.sedarplus.ca. “We are pleased with Choice Properties’ second quarter results, highlighted by robust leasing spread...
-
iVeena Delivery Systems Announces Positive End-of-Phase 1 FDA Meeting for IVMED-85
SALT LAKE CITY--(BUSINESS WIRE)--iVeena Delivery Systems, Inc., “iVeena” a clinical-stage ophthalmic pharmaceutical company developing innovative therapies for eye diseases, today announced a successful End-of-Phase 1 Type B meeting with the U.S. Food and Drug Administration (FDA) for IVMED-85, an investigational, non-atropine eye drop being developed for the treatment of pediatric myopia. The meeting followed the recently announced successful completion of iVeena's Phase 1 clinical study evalu...
-
Arcus Biosciences Announces Clinical Supply Agreement with AVEO Oncology to Evaluate Casdatifan in Combination with Tivozanib for Advanced Kidney Cancer Patients
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE: RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer and inflammatory and autoimmune diseases, today announced a clinical supply agreement with AVEO Oncology, an LG Chem company (“AVEO”). Under the agreement, the companies will evaluate casdatifan, Arcus’s investigational small-molecule HIF-2α inhibitor, in combination with tivozan...
-
Delek Logistics Partners, LP Increases Quarterly Cash Distribution to $1.135 per Common Limited Partner Unit
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Delek Logistics Partners, LP (NYSE: DKL) (“Delek Logistics”) today declared its quarterly cash distribution for the second quarter 2026 of $1.135 per common limited partner unit, or $4.54 per common limited partner unit on an annualized basis. The second quarter 2026 cash distribution is payable on August 10, 2026, to unitholders of record on August 3, 2026. About Delek Logistics Partners, LP Delek Logistics is a midstream energy master limited partnership hea...
-
BlackRock Science and Technology Trust (BST) and BlackRock Science and Technology Term Trust (BSTZ) Announce Special Distributions
NEW YORK--(BUSINESS WIRE)--BlackRock Science and Technology Trust (NYSE: BST) and BlackRock Science and Technology Term Trust (NYSE: BSTZ) (each, a "Fund" and together, the "Funds") announced today the declaration of special distributions, payable on September 30, 2026 to shareholders of record as of September 15, 2026 (ex-date September 15, 2026). The special distributions reflect substantial realized gains generated by the Funds' strong investment performance, including cumulative fiscal year...